EU Social Insurance

Less than 24hrs to go until the 3rd ESIP Annual Forum in Brussels tomorrow! Here is the agenda esip.eu/events/3rd-esi… MEPs @JarubasAdam, @AndrasKulja, @V_Andriukaitis, @vlad_voiculescu and @MetzTilly, @EU_Social reps & numerous ESIP experts will be there! #SocialEurope

It is a privilege to welcome these esteemed Members of the European Parliament to the 3rd ESIP Annual Forum in Brussels on 15 October 'The welfare states & Europe’s competitiveness: Friends or foes?' #ESIPForum #SocialSecurity #SocialEurope shorturl.at/M4qJO

Mobility of workers & workforce shortages: How do we solve this conundrum? What are the implications for #socialprotection? ESIP experts will offer their insights during the 3rd ESIP Annual Forum in Brussels on 15 October! #ESIPForum #MeetTheSpeakers shorturl.at/ho11S

A strong welfare state for a socially robust single market: The role of social security 3rd ESIP Annual Forum (Brussels, 15 October 2024) All-day event, 4 sessions, 20 speakers, 3 MEPs Register today! esip.eu/news/3rd-esip-… #SocialEurope #SocialSecurity #SocialProtection

Register today and join us in Brussels on 15 October for the 3rd ESIP Annual Forum Panel III of the Forum composed of ESIP experts will discuss the high prices of #medicines & much more! esip.eu/news/3rd-esip-… #SocialEurope #accesstomedicines #socialprotection

Today Director @YNatsis speaks at @EU2024BE conference on unmet #health-related #needs. Needs-driven policies maintain #healthcare systems #sustainable, but how? 🔸consistent & clear #UMN definition 🔹#evidence-based policies 🔸focus on #affordability 🔍 shorturl.at/fmnpz

Join us in Brussels on 27 March to reflect on #pensions' #adequacy & #sustainability. How do we ensure #socialprotection in #oldage including #longtermcare benefits & services? Few seats left-Register today t.ly/Bat0d #Equity #SocialEurope #Solidarity

Lengthy protection & exclusivity periods delay competition & have massive cost implications. Affordable access to treatment & sustainability of healthcare systems = at stake. @woelken @WeissPernille @Frederiqueries @AMALRICCatheri1 @MetzTilly @TomislavSokol

ESIP's Members, public payers' demands for #EUPharmaRevision: - Baseline for regulatory data protection (RDP) down to 6 years - Cumulative duration of regulatory protection should NOT exceed existing threshold - TEVs = no go Here are our recommendations: shorturl.at/fmnpz

Director @YNatsis joins today #JarubasEUpharmaceuticalRoundtable 📢#HealthcarePayers call to rebalance the #EUpharma ecosystem: priority is #Affordability & #StrongEvidence for effective treatment Find more in our position💊 bit.ly/40uQ8lW

Director @YNatsis mentions the value of a regulatory framework that promotes #competition “The #EUPharmaRevision has the potential to rebalance the system and ensure that #biosimilar and #generic products enter the market earlier” Find out how🔎 bit.ly/40uQ8lW

Today we join the 7th #biosimilars stakeholder event hosted by @EU_Health Losses of #exclusivities are expected in the near future: how to address lack of #biosimilar competition, reboost the biosimilar pipeline, promote biosimilar #uptake and #access?

.@YNatsis: we need to bring closer regulators, #HTA and #payers to align our #StrongEvidence requirements and our understanding of neglected medical and societal #needs More in our proposals on the #EUPharmaRevision ➡️ bit.ly/40uQ8lW

What are the consequences of a supply-driven #HealthPolicy agenda and overall financialisation of #pharma? 🔹#evidence gaps 🔸neglected societal #needs 🔹#price hikes Combined with #budget cuts: worrisome trends for the #sustainabily of #HealthSystems and #WelfareStates

Director @YNatsis on stage today at KCE 20th Anniversary symposium: how is the #pharma ecosystem changing? What is the legacy of the #pandemic and global #permacrises? What role for the #EUPharmaRevision: a revolution for #StrongEvidence based decisions or much of the same?

Discussing #StrongEvidence vs uncertainties, Denis Lacombe, @EORTC Director General calls to always push for the most robust methodology to generate evidence. “We often hear that clinical studies cannot be randomised, but they could” We agree✅

Attending today the 2nd HTA Stakeholder Network meeting. Increased uncertainty at the time of approval creates problems down the road. We need to tackle the evidence gaps early on. Here is how: bit.ly/40uQ8lW #StrongEvidence #SustainableHealthcare

.#EUSocialForum 2023 day 2, focus on #algorithmic management & the #labourmarket. How compatible is it with critical thinking? Can we ensure that the creative thinking of the workers does not get lost? More questions, than answers at this stage. #SocialEurope #SocialProtection

Big day in Brussels today with the annual, flagship event of @EU_Social. #AI in the spotlight, lots on the #platformWorkers directive #EUSocialForum2023 The 2nd #ESIPAnnualForum (Brussels, 12 October 2023) touched upon very similar themes from the #socialsecurity perspective!

“It affects white collar jobs as opposed to the past where many changes were limited to blue collar jobs” notes the head of the German Federal Employment Agency (BA) #EUSocialForum

Attending #EUSocialForum, the annual flagship event of @EU_Social in Brussels today. Emphasis on #AI & the #worldofwork. ESIP Member, the German Federal Employment Agency now on plenary: “We have a decade of automation ahead of us-important to communicate why we do it”